Tanja L. Ulrich
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nocturnal Cerebral Oxygenation in Low-Altitude Residents With Pulmonary Vascular Disease Staying Overnight at High Altitude. Data From a Randomized, Controlled, Crossover Trial.
Journal: Pulmonary circulation
Published: March 30, 2026
Effect of an Overnight Stay at 2,500 Meters on Nocturnal Hypoxemia and Sleep-disordered Breathing in Patients with Pulmonary Vascular Disease: A Randomized Clinical Trial.
Journal: Annals of the American Thoracic Society
Published: March 14, 2025
SARS-CoV-2 Transmission during High-Altitude Field Studies.
Journal: High altitude medicine & biology
Published: April 18, 2024
Heart rate variability in pulmonary vascular disease at altitude: a randomised trial.
Journal: ERJ open research
Published: March 10, 2024
Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.
Journal: European heart journal
Published: September 08, 2023
The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial.
Journal: The European respiratory journal
Published: June 13, 2023
Validation of Noninvasive Assessment of Pulmonary Gas Exchange in Patients with Chronic Obstructive Pulmonary Disease during Initial Exposure to High Altitude.
Journal: Journal of clinical medicine
Published: November 30, 2022
Hypoxia-altitude simulation test to predict altitude-related adverse health effects in COPD patients.
Journal: ERJ open research
Published: September 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026